StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.37−0.34 (-3.90%)

Close on Nov 20, 2026Market cap $2.84BP/E –Yield –

Telix Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $426.44M, up 26.9% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$426.44M+26.9%
FY2024Dec 31, 2024$336.16M+60.4%
FY2023Dec 31, 2023$209.53M–

More Telix Pharmaceuticals figures

See a number that looks wrong?